Thirteen patients who received liver transplants at the National Liver Transplant Unit between January 1986 and March 1987 were studied with extensive monitoring and frequent intraoperative biochemical and haematological profiles. Anaesthetic technique was standardised for all patients. Retrospective analysis of this data confirms that patient homeostasis is most disturbed at the time of revascularisation of the donor liver. In this series, revascularisation was associated with marked changes in all measured haemodynamic parameters (arterial blood pressure, cardiac index, heart rate, and filling pressures). There was also a significant fall in pH with revascularisation, followed by a gradual rise during the final phases of the operation. Potassium levels often rose sharply with revascularisation but then decreased during the rest of the operative period. Ionised calcium levels did not change significantly at any stage; however, all patients were given calcium intraoperatively. Coagulation profiles were often abnormal preoperatively. The transplant procedure was associated with further abnormalities in both coagulation and fibrinolysis. Patient temperatures were maintained at normal levels throughout the procedure.
interruptions to normal splanchnic blood flow and venous return from the lower half of the body which leads to haemodynamic instability and more profound metabolic acidosis. When possible, an attempt is made to minimise this problem by instituting venovenous bypass from the left iliac vein and the portal vein to the left axillary vein, using a centrifugal blood pump. This manoeuvre also reduces blood loss and improves surgical exposure in patients with portal hypertension. Until anastamosis of the new liver is completed, the patient is in the anhepatic state. Anastamosis of the donor liver to the inferior vena cava exposes the patient to a high risk of air embolism, either directly entrained or flushed out from the donor liver. Next, revascularisation of the donor liver may infuse into the recipient's circulation the remains of the perfusate solution, which may Anaesthesia and Intensi"e Care. Vol. 17. No. 1. Februar) '. 1989 have high levels of potassium, glucose, and lactic acid. Hepatocytes in the donor liver suffer from a variable degree of ischaemic damage which may not only impair normal function for some time but may also cause the liver to take up or excrete large amounts of potassium, glucose, calcium, and other substances.
Bilateral Fritsch retractors attached to lithotomy poles by chains provide the extensive retraction needed for adequate surgical exposure. This compromises respiration intraoperatively and often leads to basal atalectasis postoperatively.
In general, the period immediately following revascularisation is associated with the greatest fluctuations in the recipient's haemodynamics, biochemistry, and coagulation.
. Invasive monitoring of the cardiovascular system and frequent biochemical and haematological assays are routinely performed on all patients undergoing liver transplantation, in particular at the time of revascularisation. This allows early detection and treatment of abnormalities so as to minimise any deviations from baseline values.
The operation is considered in five phases: PHASE 1 -before induction of anaesthesia, PHASE 2 -induction of anaesthesia to removal of liver, PHASE 3 -anhepatic phase, PHASE 4 -revascularisation of donor liver in recipient, PHASE 5 -biliary anastomosis and closure.
MATERIALS AND METHODS
Thirteen patients (ages 1-50 years) received fourteen liver transplants at Royal Prince Alfred Hospital between January 1986 and March 1987. The indications for surgery are shown in Table 1 . All patients were monitored with direct measurement of arterial pressure and central venous pressure. Pulmonary artery pressure and cardiac output were monitored in all patients except small children. Central vascular temperature was measured with the pulmonary artery catheter (except in small children in whom nasopharyngeal temperature was monitored). ECG, airway pressures, and urine output were also monitored. Frequent biochemical and haematological profiles were performed. An outline of the protocol for measurement and sampling times for the five phases of the procedure is shown in Table 2 . All pressure measurements were made using Gould non-disposable transducers, and a Grass 8-channel recorder. Cardiac output was measured by the thermodilution technique using an Edwards cardiac output computer.
All biochemical and haematological assays were performed by the usual biochemistry and haemotology laboratory staff of the Royal Prince Alfred Hospital.
Anaesthesia was standardised for all patients: pre-oxygenation was followed by a sleep dose of thiopentone and suxamethonium 1.0-1.5 mg kg-I. The trachea was then intubated and the patient ventilated with 30% oxygen in air. Isoflurane or enflurane was used for the maintenance of anaesthesia and d-tubocurarine was used to provide muscle relaxation. At the completion of surgery all patients were kept intubated and ventilated until stable in the intensive care unit. Morphine was given in the closing stages of surgery for postoperative analgesia and sedation. Results are given as mean values and standard deviations. 'Significant' is used in the statistical sense for comparisons where P< 0.05.
Blood and fluid replacement
Mean numbers of units of blood, plasma and other blood components including blood scavenged using the cell saver are given in Table 3 .
Haemodynamic changes during
transplantation (see Table 4 and Figure 1 ) Mean heart rate before induction of anaesthesia was 105 bpm (SD 22). It did not alter significantly prior to Phase 4. There was a 9% increase in heart rate (P < 0.01) within 15 minutes of revascularisation, which was sustained until surgery was completed.
Mean arterial blood pressure (MABP) also remained stable prior to Phase 4. One minute after revascularisation there was a 15% fall in MABP (P< 0.01). Values were back to prerevascularisation levels within 15 minutes of revascularisation, and remained at similar levels until the end of surgery. .. Cardiac index in Phase 1 was 5.7 litres min -lm -2 (SD 0.9). There was no significant change until revascularisation, at which time cardiac index increased by 22% (P < 0.05), five minutes after revascularisation. Cardiac index then gradually returned to baseline levels by Phase 5. Central venous pressure (CVP) was also stable until Phase 4 (range: 6-7 mmHg (SD 5». Within one minute of revascularisation, there was a 44% increase in CVP (P < 0.05). This was, however, only mmoll-1 (SO 3) before surgery, to a low of 17 mmol 1-I (SO 5) at five minutes after revascularisation (P> 0.05). Subsequently, bicarbonate levels returned to pre-operative baseline levels.
There was no significant change in potassium values prior to Phase 4 (baseline value: 3.7 mmol 1-1). One minute after revascularisation, there was an immediate short-lived rise in potassium (P> 0.05), followed by a significant and sustained fall from 3.8 mmoll-1 (SO 1.1) to 2.8 mmoll-I (SO 0.6), by Phase 5 (P< 0.01). Although the rise in mean potassium one minute after revascularisation was not statistically significant, individual potassium values at this time increased to levels as high as 6.7 mmoll-I .
Ionised calcium levels did not change significantly during the operative procedure.
Blood sugar levels increased in the period prior to revascularisation from 8.2 mmoll-1 ~SO 5.0). in Phase 1, to 17.9 mmoll-I (SO 4.6) ImmedIately before revascularisation 4.0 .' (P< 0.01). Phase 4 was associated with a further rise in blood sugar to 23.0 mmoll-1 (SO 4.9) at fifteen minutes postrevascularisation (P < 0.01). Blood sugar levels then fell to 17.5 mmol 1-I (SD 6.1; P< 0.01) by Phase 5. (Table 6 and Figure 4 ) Prothrombin Index (PI) at commencement of surgery was 78 (SD 12). There was no significant change from this value throughout the procedure, with a PI at Phase 5 of 72 (SD 20).
Haematological changes during transplantation
Activated Partial Thromboplastin Time (APTT) at the start of surgery was 55 seconds (SO 33). This did not change significantly before revascularisation: however, within one minute of revascularisation, a significant rise occurred (79 seconds (SD 48; P < 0.05», which persisted until the later part of Phase 4, at which time the APTT gradually decreased to pre-surgicallevels (57 seconds (SO 37».
In all but two cases there was an increase in titre of fibrin degradation products at some stage: the magnitude and timing of this rise was variable, and there was insufficient data to correlate the rise with the timing or magnitude of blood replacement.
Platelet count decreased throughout the procedure from 143 10 9 1-1 (SD 76) at the commencement of surgery to 103. 10 9 1-1 (SO 38) by Phase 5 (P> 0.05).
Temperature changes during transplantation
Temperature prior to induction of anaesthesia was 37.1 °C (SD 0.6). At the completion of surgery, temperature was 36.9°C (SO 0.8). This fall was not statistically significant (P < 0.05).
DISCUSSION
The data presented here was collected while following the routine anaesthetic protocol for liver transplantation developed at the Royal Prince Alfred Hospital. The key purpose of this monitoring protocol was to detect any changes in the patient's internal milieu as early as possible so that corrective measures could minimise any deviations from baseline values. Another important function of this data was to provide for a more objective, retrospective analysis of any perioperative events. A third function was to allow us to compare (at least crudely), our success at maintaining stable conditions intraoperatively with the success of other units performing hepatic transplants.
The problems associated with retrospective data analysis are well known. In particular, one must be aware that throughout this procedure our therapeutic interventions were deliberately altering many of the measured parameters, so that in fact any change which reached statistical significance represented a therapeutic failure (perhaps unavoidable). Conversely, parameters that did not change significantly were not necessarily 'unchanging'; often change was present but minimised by appropriate therapy. Given this proviso, the data has been interpreted as follows.
Haemodynamic measurements prior to induction of anaesthesia confirm a high output state and decreased peripheral resistance. This probably relates to arteriovenous shunting present in liver disease. Anxiety associated with the impending surgery may also be a factor; however, the absence of any significant change in these values after the induction of anaesthesia militates against this hypothesis.
Haemodynamic changes are most marked during revascularisation. This is associated with a fall in MABP and a rise in cardiac index, heart rate, and CVP. The probable cause of these changes is the release of vasoactive substances from the graft liver at revascularisation causing a decrease in systemic and pulmonary resistance. I In anticipation of the changes associated with revascularisation, we are careful to ensure that ionised calcium levels are normal and that the patient is 'well filled'. The importance of maintaining normal ionised calcium to prevent significant falls in cardiac index at revascularisation have been previously documented. 2 Our zealous blood volume replacement prior to revascularisation was a contributing factor to the rise in CVP seen after revascularisation. However, this stage was not associated with any occurrence of cardiovascular collapse, bradycardia, or other arrythmias, as have occurred in other centres.
The acidosis and rise in PaC02 at revascularisation are the result of lactic acid and hydrogen ions flushed out of the donor liver at revascularisation. Treatment of some patients with bicarbonate at this stage would have contributed to the elevation in PaC02 levels, and also minimised the measured fall in bicarbonate levels and pH.
After revascularisation (i.e. late Phase 4 and Phase 5), pH increased significantly and often there was postoperative metabolic alkalosis. This rise in pH is due to metabolism of the large quantities of citrate infused with blood transfusion. Re-uptake of hydrogen ions and metabolism oflactic acid by the new liver may also contribute.
The early rise in potassium seen one minute after revascularisation was probably a result of incomplete flushing out of the liver preservation solution prior to re vascularisation. This solution is rich in Anaesthesia and Intensive Care. Vol. 17. No. I. February. 1989 potassium which has been lost from the hepatocytes during liver preservation. (The preservation solution initially has a low potassium: 2.5 mmol I-I.)
The subsequent fall in potassium concentration during Phases 4 and 5 is the result of re-uptake of potassium by the transplanted liver, aggravated by a shift of potassium into all cells secondary to the developing metabolic alkalosis. The extent of this decrease in serum potassium concentration was modified as most patients were given potassium infusions and/or boluses during Phases 4 and 5.
Although there was no statistically significant fall in ionised calcium levels throughout the procedure, this was mainly due to calcium chloride or glucoriate given during Phases 3 and 4. Most, if not all, of the fall in ionised calcium can be ascribed to high levels of citrate from the blood and blood products transfused, especially during the anhepatic phase when presumably all citrate metabolism ceases.
During the early stages of the operation, blood sugar concentration rose significantly. Metabolic requirements for glucose are reduced in the paralysed and anaesthetised patient, levels of insulin antagonists are elevated with the stress response to surgery and some glucose is infused with each unit of blood or plasma. Like potassium, however, glucose seems to be taken up by the new liver, causing a fall in blood sugar in the later stages of the operation and postoperatively.
Coagulation profile is usually abnormal in patients presenting for liver transplantation, especially in those with widespread parenchymal damage (e.g. long-standing a-I antitrypsin deficiency or fulminant hepatitis), in contrast to those patients with more localised areas of liver damage (e.g. malignancy).3 In this series, preoperative PI was 78 (SD 12) and APTT was 55 seconds (SD 33). This is due to decreased levels of all coagulation factors except factor VIII and fibrinogen which are often normal or elevated in patients presenting for liver transplantation. 4 Liver transplantation tends to further destabilise coagulation because of dilutional coagulopathy, heparin effect, fibrinolysis, and possibly hypocalcaemia.
In view of these problems, our protocol for fluid replacement during liver transplantation involves the transfusion of equal numbers of units of fresh frozen plasma and packed cells. Further replacement of coagulation factors and platelets is then made on the basis of laboratory tests and clinical evidence of coagulopathy.
Despite this protocol, APTT increased significantly at revascularisation from 51 seconds (SD 27) to 79 seconds (SO 48). The mechanism of this is not understood, although fibrinolysis and heparin effect at the time of revascularisation may be significant factors (titres of fibrin degradation products increased during all but two of our transplants). There was no significant change in PI using this replacement protocol, nor was there a significant fall in platelet count intraoperatively. However, an average of 22 units of platelets (SD 17) were infused during the procedure on the basis of clinical oozing and platelet count of less than 100.10 9 1-'. Hypothermia is a commonly described problem after liver transplantation for several reasons, including the need for rapid and often massive transfusion of inadequately warmed blood and blood products, prolonged surgery in the anaesthetised and paralysed patient, and prolonged exposure of the abdominal contents. Another potential source of 'coolth' is the ice-cold liver preservation solution. In this series there was no significant change in temperatures over the operative period. In addition to the usual safeguards, such as keeping the patient well covered, heating and humidifying inspired gases, and the use of warming blankets, we also maintained the operating theatre temperature at 24°C, and used a specially constructed rapid infusion system which utilises a roller pump in series with a high capacity water bath and 1200 watt heater. Temperatures in the blood storage chamber (cardiotomy reservoir) and the patient lines were monitored continuously. The water bath temperature was manually controlled to ensure that, regardless of infusion rate, the temperature of the infused blood remained at 37°C.
To minimise the infusion of cold liver preservation solution into the recipient, the donor liver was repeatedly flushed with a prewarmed solution prior to revascularisation.
These data confirm the need for aggressive monitoring of the cardiovascular system and frequent biochemical and haematological assays during orthotopic liver transplantation, especially during the highly labile period following revascularisation. The efficacy of the added measures taken to maintain normal body temperatures, in particular the rapid infusion system, is also seen. Further studies are required to determine the precise etiology of the various changes described above. A more complete knowledge of these changes should enable us to minimise or even eradicate these fluctuations from baseline values.
